BioPlus Acquisition Corp. (BIOS) — Financial statements
Income statement, balance sheet, and cash flow for BioPlus Acquisition Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00↓100.0% | 709↓13.3% | 817↓12.7% | 936 | |
| Cost of Revenue | 1 | 0.00↓100.0% | 466↓15.0% | 548↓18.2% | 670 | |
| Gross Profit | -1 | 0.00↓100.0% | 243↓9.8% | 269↑1.4% | 266 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00↓100.0% | 47↓25.3% | 63↓4.1% | 66 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00↑620.9% | 0.00↓100.0% | 47↓25.3% | 63↓4.1% | 66 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 190↓14.1% | 221↑11.7% | 198 | |
| Operating Expenses | 0.00↑621.0% | 0.00↓100.0% | 237↓16.6% | 284↑7.7% | 264 | |
| Total Costs & Expenses | 1↑720870.3% | 0.00↓100.0% | 703↓15.5% | 832↓10.9% | 934 | |
| Operating Results | ||||||
| Operating Income | -1↓720825.9% | -0.00↑100.0% | -109↓105.9% | -53↑32.2% | -78 | |
| Depreciation & Amortization | 0.23↓3.4% | 0.24↓99.0% | 24↓14.9% | 28↑28.7% | 22 | |
| EBITDA | -1↓12352420.7% | 0.00↑100.0% | -85↓240.0% | -25↑55.5% | -56 | |
| EBIT | 0.00 | 0.00↑100.0% | -108↑9.3% | -120↓69.3% | -71 | |
| Interest & Other Income | ||||||
| Net Interest Income | 3↑33407073.0% | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Income | 3↑33407073.0% | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00↑100.0% | -57↓10.2% | -52↓36.4% | -38 | |
| Non-Operating Income | 0.00 | 0.00↑100.0% | -0.10↓100.1% | 67↑1040.8% | -7 | |
| Other Income / Expenses | 3↑33407073.0% | 0.00↓100.0% | 58↑491.2% | -15↓132.5% | 45 | |
| Income Before Tax | 2↑1305187.0% | -0.00↑100.0% | -51↑24.3% | -67↓108.0% | -32 | |
| Income Tax Expense | -3 | 0.00↓100.0% | 0.60↓99.1% | 64↑3080.0% | 2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 5↑3375933.7% | -0.00↑100.0% | -52↑60.6% | -131↓280.8% | -34 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 5↑3375933.7% | -0.00↑100.0% | -52↑60.6% | -131↓280.8% | -34 | |
| Bottom-Line Net Income | 5↑3375933.7% | -0.00↑100.0% | -52↑60.6% | -131↓280.8% | -34 | |
| EPS (Basic) | 0.01↑138.7% | -0.02↑94.5% | -0.40↑62.3% | -1.06↓186.5% | -0.37 | |
| EPS (Diluted) | 0.20↑1000.9% | -0.02↑94.5% | -0.40↑62.3% | -1.06↓186.5% | -0.37 | |
| Weighted Average Shares | 598↑8695056.4% | 0.01↓100.0% | 128↑3.3% | 124↑32.1% | 94 | |
| Weighted Average Diluted Shares | 26↑384409.1% | 0.01↓100.0% | 128↑3.3% | 124↑32.1% | 94 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.